Saltar al contenido

Thermo Fisher Scientific Inc. (TMO) stock: revenue, earnings & dividend

Thermo Fisher Scientific Inc. (TMO, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener TMO · NYSE Medizintechnik & Messgeräte US-MA

Key figures

Fiscal year
2025
Revenue
44.6 bn $
Revenue growth
3.9 %
Revenue growth 5y (p.a.)
6.7 %
Net income
6.72 bn $
Net margin
15.1 %
Operating margin
17.4 %
Earnings per share (diluted)
17.74 $
Dividend per share
1.72 $
Payout ratio
9.7 %
Consecutive dividend years
14 years
Consecutive dividend raises
8 years
Dividend growth 5y (p.a.)
14.3 %
Total assets
110 bn $
Equity
53.4 bn $
Equity ratio
48.4 %
Return on equity
12.6 %
Cash
9.85 bn $
Operating cash flow
7.82 bn $
Free cash flow
6.29 bn $
Shares outstanding
370,515,868

History

Revenue by fiscal year

2016 18.3 bn $
2017 20.9 bn $
2018 24.4 bn $
2019 25.5 bn $
2020 32.2 bn $
2021 39.2 bn $
2022 44.9 bn $
2023 42.9 bn $
2024 42.9 bn $
2025 44.6 bn $

Net income by fiscal year

2021 7.73 bn $
2022 6.96 bn $
2023 5.96 bn $
2024 6.34 bn $
2025 6.72 bn $

Dividend per share

2016 0.60 $
2017 0.60 $
2018 0.68 $
2019 0.76 $
2020 0.88 $
2021 1.04 $
2022 1.20 $
2023 1.40 $
2024 1.56 $
2025 1.72 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202544.6 bn $6.72 bn $17.74 $1.72 $7.82 bn $
202442.9 bn $6.34 bn $16.53 $1.56 $8.67 bn $
202342.9 bn $5.96 bn $15.45 $1.40 $8.41 bn $
202244.9 bn $6.96 bn $17.63 $1.20 $9.15 bn $
202139.2 bn $7.73 bn $19.46 $1.04 $9.31 bn $
202032.2 bn $–15.96 $0.88 $8.29 bn $
201925.5 bn $–9.17 $0.76 $4.97 bn $
201824.4 bn $–7.24 $0.68 $4.54 bn $
201720.9 bn $–5.59 $0.60 $4.01 bn $
201618.3 bn $–5.09 $0.60 $3.26 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)